Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Kidney Fibrosis - Overview
Kidney Fibrosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Kidney Fibrosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Kidney Fibrosis - Companies Involved in Therapeutics Development
Kidney Fibrosis - Drug Profiles
Kidney Fibrosis - Dormant Projects
Kidney Fibrosis - Discontinued Products
Kidney Fibrosis - Product Development Milestones
Featured News & Press Releases
Jul 04, 2022: AD-214 program modified to maximise partnering options, extends cash runway
Jan 04, 2022: Alentis Therapeutics starts first-in-human clinical trial for the treatment of liver and kidney fibrosis
Sep 27, 2021: AdAlta announces new preclinical data presented at “Discovery on Target” meeting
Sep 08, 2021: RedHill’s opaganib reduces kidney fibrosis in preclinical study
Jun 22, 2020: Hepion Pharmaceuticals’ CRV431 demonstrates efficacy in kidney fibrosis
Nov 11, 2019: Limil Biosciences presents new preclinical data on PBI-4610 at ASN Kidney Week 2019
Oct 24, 2019: Limil BioSciences announces upcoming presentation on drug candidate PBI-4610 at ASN kidney week 2019
Jul 18, 2019: Genkyotex to launch Phase II pulmory fibrosis trial in US
Jan 14, 2019: sh Pharmaceuticals provides update on Kidney Disease drug candidate NP-160
Jan 14, 2019: sh Pharmaceuticals Announces Positive Pre-Clinical Results From a Second Study for Chronic Kidney Disease
Nov 29, 2018: Kadmon presents data on New ROCK Inhibitor clinical candidate at Anti-Fibrotic Drug Development Summit
Nov 19, 2018: sh Pharmaceuticals announces positive pre-clinical results for its lead compound NP-135 in chronic kidney disease
Aug 30, 2018: VBL Therapeutics announces publication of positive new data on its Lecinoxoid drug candidates for the treatment of rel fibrosis
Nov 13, 2017: AdAlta to present at Anti-Fibrotic Drug Development Summit in Boston
Sep 06, 2017: Pharmaxis Announces Anti Fibrotic LOXL2 Program Clears Preclinical Development And Set To Commence Phase 1 Trials
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Kidney Fibrosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Kidney Fibrosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Kidney Fibrosis - Pipeline by Accendatech Co Ltd, 2022
Kidney Fibrosis - Pipeline by AdAlta Ltd, 2022
Kidney Fibrosis - Pipeline by Alentis Therapeutics AG, 2022
Kidney Fibrosis - Pipeline by Algernon Pharmaceuticals Inc, 2022
Kidney Fibrosis - Pipeline by Anagenics Ltd, 2022
Kidney Fibrosis - Pipeline by Angion Biomedica Corp, 2022
Kidney Fibrosis - Pipeline by AstraZeneca Plc, 2022
Kidney Fibrosis - Pipeline by BiOrion Technologies BV, 2022
Kidney Fibrosis - Pipeline by CohBar Inc, 2022
Kidney Fibrosis - Pipeline by Epigen Biosciences Inc, 2022
Kidney Fibrosis - Pipeline by Evotec SE, 2022
Kidney Fibrosis - Pipeline by Future Medicine Co Ltd, 2022
Kidney Fibrosis - Pipeline by Galapagos NV, 2022
Kidney Fibrosis - Pipeline by Galectin Therapeutics Inc, 2022
Kidney Fibrosis - Pipeline by GenKyoTex SA, 2022
Kidney Fibrosis - Pipeline by Hepion Pharmaceuticals Inc, 2022
Kidney Fibrosis - Pipeline by iBio Inc, 2022
Kidney Fibrosis - Pipeline by InSilico Medicine, 2022
Kidney Fibrosis - Pipeline by Isarna Therapeutics GmbH, 2022
Kidney Fibrosis - Pipeline by Jiangxi Jemincare Group Co Ltd, 2022
Kidney Fibrosis - Pipeline by Kadmon Holdings Inc, 2022
Kidney Fibrosis - Pipeline by Liminal BioSciences Inc, 2022
Kidney Fibrosis - Pipeline by Max Biopharma Inc, 2022
Kidney Fibrosis - Pipeline by Mission Therapeutics Ltd, 2022
Kidney Fibrosis - Pipeline by NB Health Laboratory Co Ltd, 2022
Kidney Fibrosis - Pipeline by Novo Nordisk AS, 2022
Kidney Fibrosis - Pipeline by Osteoneurogen Inc, 2022
Kidney Fibrosis - Pipeline by Pharmaxis Ltd, 2022
Kidney Fibrosis - Pipeline by RedHill Biopharma Ltd, 2022
Kidney Fibrosis - Pipeline by Rubedo Life Sciences Inc, 2022
Kidney Fibrosis - Pipeline by Sanofi, 2022
Kidney Fibrosis - Pipeline by Scholar Rock Inc, 2022
Kidney Fibrosis - Pipeline by Secarna Pharmaceuticals GmbH & Co KG, 2022
Kidney Fibrosis - Pipeline by Senolytic Therapeutics Inc, 2022
Kidney Fibrosis - Pipeline by TRACON Pharmaceuticals Inc, 2022
Kidney Fibrosis - Pipeline by Transcenta Holding Ltd, 2022
Kidney Fibrosis - Pipeline by UCB SA, 2022
Kidney Fibrosis - Pipeline by Vascular Biogenics Ltd, 2022
Kidney Fibrosis - Pipeline by Vectus Biosystems Ltd, 2022
Kidney Fibrosis - Dormant Projects, 2022
Kidney Fibrosis - Dormant Projects, 2022 (Contd..1)
Kidney Fibrosis - Discontinued Products, 2022